Alternatives to 32 Biosciences

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Biopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

A global oncology company developing and commercializing innovative cancer treatments.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotech company developing next-generation gene writing tools for advanced therapies.

Biotechnology company developing novel immunotherapies for cancer.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Mabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer.

Leveraging the adaptive immune system to diagnose and treat disease.

Immunotherapy company targeting oncology and autoimmune diseases.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Biotech company developing novel therapeutics for regenerative medicine and oncology.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered platform for personalized cell therapy development and manufacturing.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Pillar Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel cancer therapies.

Developing novel therapeutics for cancer by targeting the tumor microenvironment.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Develops and manufactures biologics for therapeutic applications.

Biotech company focused on developing therapies to extend human healthspan and lifespan.

Metly empowers pharma companies to accelerate product launches through intelligent opportunity detection and partner matching.

Global marketplace connecting researchers with human biospecimens for life science research.

Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

VISEN Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for inflammatory and fibrotic diseases.

AI-powered spatial biology platform for precision medicine and drug development.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.